Prediction model establishment of prognosis factors for distant metastasis of hepatocellular carcinoma based on the SEER database

被引:0
作者
Wu, Jixuan [1 ,4 ]
Zhang, Chun [1 ,4 ]
Zhang, Youjia [5 ]
He, Rui [2 ]
Wang, Qin [3 ]
Zhang, Lei [1 ]
Hu, Jing [2 ]
Wan, Runlan [2 ,4 ]
机构
[1] Southwest Med Univ, Sch Pharm, Luzhou 646000, Sichuan, Peoples R China
[2] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou 646000, Sichuan, Peoples R China
[3] Dazhou Vocat Coll Chinese Med, Dazhou 635000, Peoples R China
[4] Southwest Med Univ, Sch Pharm, Dept Pharmacol, Key Lab Luzhou City Aging Med, Luzhou 646000, Peoples R China
[5] Southwest Med Univ, Sch Publ Hlth, Luzhou 646000, Peoples R China
关键词
Nomogram; Hepatocellular carcinoma; Distant metastasis; SEER; NANOPARTICLES; THERAPY;
D O I
10.1016/j.canep.2024.102729
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Distant metastasis in hepatocellular carcinoma (HCC) is an important indicator of poor patient prognosis. Identifying patients who are at high risk of metastasis early on is essential for creating personalized treatment plans, yet currently, there is a scarcity of effective predictive tools. Objective: To investigate the effects of different factors on distant metastasis in HCC patients and to establish a clinical prediction model for predicting distant metastasis in HCC patients. Methods: Our study retrospectively examined 22,318 patients diagnosed with confirmed HCC from the SEER database. Prognostic factors for developing distant metastases in HCC patients were identified by univariate and multivariate logistic regression analyses. Utilizing data from a multivariate logistic regression analysis, we created a nomogram. Its predictive precision was evaluated by analyzing the calibration curve, the area under the curve (AUC) of the receiver operating characteristic curve, decision curve assessment (DCA), and KaplanMeier (KM) curve analysis of overall survival. Finally,the nomogram was visualized with an online calculator. Results: We identified six independent prognostic factors: ethnicity, marital status, tumor size, survival time, surgery, and radiotherapy. The nomogram constructed from these six factors showed good calibration, discrimination, and clinical application value after calibration curve analysis, receiver operating characteristic curve analysis and DCA curve analysis. Besides, Kaplan-Meier survival curves also demonstrated that this nomogram had predictive accuracy. Conclusion: In this research, a nomogram model was created to accurately predict distant metastasis risk in patients with HCC. This study provides guidance for optimizing individual therapies and making better clinical decisions.
引用
收藏
页数:7
相关论文
共 34 条
[1]   Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion [J].
Cai, Zhixiong ;
Su, Xiaoping ;
Qiu, Liman ;
Li, Zhenli ;
Li, Xiaolou ;
Dong, Xiuqing ;
Wei, Fuqun ;
Zhou, Yang ;
Luo, Liuping ;
Chen, Geng ;
Chen, Hengkai ;
Wang, Yingchao ;
Zeng, Yongyi ;
Liu, Xiaolong .
MOLECULAR CANCER, 2021, 20 (01)
[2]   DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma [J].
Chen, Yunfei ;
Wang, Xu ;
Deng, Xiaofan ;
Zhang, Yu ;
Liao, Rui ;
Li, Youzan ;
Yang, Hongji ;
Chen, Kai .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[3]   Real-World Data on Clinical Outcomes of Patients with Liver Cancer: A Prospective Validation of the National Cancer Centre Singapore Consensus Guidelines for the Management of Hepatocellular Carcinoma [J].
Chew, Xin Hui ;
Sultana, Rehena ;
Mathew, Eshani N. ;
Ng, David Chee Eng ;
Lo, Richard H. G. ;
Toh, Han Chong ;
Tai, David ;
Choo, Su Pin ;
Goh, Brian Kim Poh ;
Yan, Sean Xuexian ;
Loke, Kelvin Siu Hoong ;
Thang, Sue Ping ;
Gogna, Apoorva ;
Venkatanarasimha, Nanda Karaddi ;
Tong, Aaron K. T. ;
Moe, Fiona N. N. ;
Chua, Jacelyn S. S. ;
Ang, Reiko W. T. ;
Ong, Aldwin D. ;
Ng, Ashley W. Y. ;
Hoang, Marjorie T. Q. ;
Too, Chow Wei ;
Thng, Choon Hua ;
Chan, Wan Ying ;
Kee, Wanyi ;
Chan, Jaclyn H. M. ;
Irani, Farah ;
Leong, Sum ;
Lim, Kiat Hon ;
Wang, Michael L. C. ;
Chow, Pierce K. H. .
LIVER CANCER, 2021, 10 (03) :224-239
[4]   Combined Transarterial Embolization/Chemoembolization-Based Locoregional Treatment with Sorafenib Prolongs the Survival in Patients with Advanced Hepatocellular Carcinoma and Preserved Liver Function: A Propensity Score Matching Study [J].
Chien, Shih-Chieh ;
Chen, Chiung-Yu ;
Cheng, Pin-Nan ;
Liu, Yi-Shan ;
Cheng, Hsiu-Chi ;
Chuang, Chiao-Hsiung ;
Chang, Ting-Tsung ;
Chiu, Hong-Chi ;
Lin, Yih-Jyh ;
Chiu, Yen-Cheng .
LIVER CANCER, 2019, 8 (03) :186-202
[5]   KSR2-14-3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma [J].
Gao, Chao ;
Wang, Si-wei ;
Lu, Jia-cheng ;
Chai, Xiao-qiang ;
Li, Yuan-cheng ;
Zhang, Peng-fei ;
Huang, Xiao-yong ;
Cai, Jia-bin ;
Zheng, Yi-min ;
Guo, Xiao-jun ;
Shi, Guo-ming ;
Ke, Ai-wu ;
Fan, Jia .
BIOMARKER RESEARCH, 2022, 10 (01)
[6]   Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma [J].
Gigante, Elia ;
Hobeika, Christian ;
Le Bail, Brigitte ;
Paradis, Valerie ;
Tougeron, David ;
Lequoy, Marie ;
Bouattour, Mohamed ;
Blanc, Jean-Frederic ;
Ganne-Carrie, Nathalie ;
Tran, Henri ;
Hollande, Clemence ;
Allaire, Manon ;
Amaddeo, Giuliana ;
Regnault, Helene ;
Vigneron, Paul ;
Ronot, Maxime ;
Elkrief, Laure ;
Verset, Gontran ;
Trepo, Eric ;
Zaanan, Aziz ;
Ziol, Marianne ;
Ningarhari, Massih ;
Calderaro, Julien ;
Edeline, Julien ;
Nault, Jean-Charles .
LIVER CANCER, 2022, 11 (05) :460-473
[7]   Improved Delivery Performance of n-Butylidenephthalide-Polyethylene Glycol-Gold Nanoparticles Efficient for Enhanced Anti-Cancer Activity in Brain Tumor [J].
Hsing, Ming-Tai ;
Hsu, Hui-Ting ;
Chang, Chih-Hsuan ;
Chang, Kai-Bo ;
Cheng, Chun-Yuan ;
Lee, Jae-Hwan ;
Huang, Chien-Li ;
Yang, Meng-Yin ;
Yang, Yi-Chin ;
Liu, Szu-Yuan ;
Yen, Chun-Ming ;
Yang, Shun-Fa ;
Hung, Huey-Shan .
CELLS, 2022, 11 (14)
[8]   The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors [J].
Hu, Chao ;
Liu, Yinhua ;
Jiang, Shan ;
Chen, Hongjin ;
Xu, Haojun ;
Hu, Junhong ;
Li, Congzhu ;
Xia, Hongping .
CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (02)
[9]   Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis [J].
Huang, Xiao-Yong ;
Zhang, Peng-Fei ;
Wei, Chuan-Yuan ;
Peng, Rui ;
Lu, Jia-Cheng ;
Gao, Chao ;
Cai, Jia-Bing ;
Yang, Xuan ;
Fan, Jia ;
Ke, Ai-Wu ;
Zhou, Jian ;
Shi, Guo-Ming .
MOLECULAR CANCER, 2020, 19 (01)
[10]   Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma [J].
Liu, Sai-Lan ;
Bian, Li-Juan ;
Liu, Ze-Xian ;
Chen, Qiu-Yan ;
Sun, Xue-Song ;
Sun, Rui ;
Luo, Dong-Hua ;
Li, Xiao-Yun ;
Xiao, Bei-Bei ;
Yan, Jin-Jie ;
Lu, Zi-Jian ;
Yan, Shu-Mei ;
Yuan, Li ;
Tang, Lin-Quan ;
Li, Jian-Ming ;
Mai, Hai-Qiang .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)